Notch信号相关受体/配体在皮肤恶性黑素瘤中的表达

摘要/Abstract

摘要： 目的检测Notch信号通路中Notch1、Notch4、Jagged1以及Dll4在皮肤恶性黑素瘤组织中的表达，初步探讨Notch信号通路在黑素瘤发病机制中的作用。方法免疫组化SP法检测40例恶性黑素瘤及15例色素痣石蜡标本中Notch1、Notch4、Jagged1以及Dll4的表达模式和表达强度。采用SPSS21.0软件进行卡方检验及Spearman秩相关分析。结果在40例黑素瘤组织（31例阳性表达）及15例色素痣组织（3例阳性表达）Notch1的表达率差异有统计学意义（χ2 = 15.281，P = 0.000），原位（18例）及侵袭性黑素瘤（22例）间Notch1表达强度差异无统计学意义（χ2 = 0.631，P = 0.427）。Notch4、Jagged1以及Dll4的表达率在恶性黑素瘤与色素痣之间差异均有统计学意义（均P < 0.05），三者表达强度在原位与侵袭性黑素瘤之间差异亦均有统计学意义（P < 0.05）。在黑素瘤组织中，Notch1与Jagged1的表达呈正相关（rs = 0.350，P = 0.027），与Dll4的表达亦呈正相关（rs = 0.562，P = 0.000），但是Jagged1与Dll4的表达呈负相关（rs = -0.734，P = 0.000）。结论 Notch信号通路异常可能是黑素瘤的发病机制之一，但具体作用机制有待进一步研究。

Abstract: Liu Bai, Yu Wanting, Cheng Wei, Shao Xuebao, Jiang Yiqun Department of Pathology, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China Corresponding author: Jiang Yiqun, Email: yiqunjiang@qq.com 【Abstract】 Objective To determine the of Notch pathway receptors （Notch1 and Notch4） and ligands （Jagged1 and Dll4） in cutaneous malignant melanoma （CMM） tissues, and to preliminarily explore the role of the Notch signaling pathway in the pathogenesis of CMM. Methods Immunohistochemical study was performed to determine the pattern and intensity of Notch1, Notch4, Jagged1 and Dll4 in 40 paraffin?embedded CMM specimens and 15 paraffin?embedded pigmented nevus specimens. Statistical analysis was carried out by chi?square test and Spearman rank correlation analysis with the SPSS 21.0 software. Results Notch1 was detected in 31 （77.5%） of 40 CMM specimens, as well as in 3 of 15 pigmented nevus specimens, and the positive rates significantly differed between the two groups （χ2 = 15.281, P < 0.001）. However, no significant difference in the intensity of Notch1 was observed between 18 in situ melanoma tissues and 22 invasive melanoma tissues （χ2 = 0.631, P = 0.427）. In addition, the positive rates of Notch4, Jagged1 and Dll4 were also significantly higher in the CMM group than those in the pigmented nevus group （all P < 0.05）, and the intensity of Notch4, Jagged1 and Dll4 significantly differed between in situ and invasive melanoma tissues （all P < 0.05）. In CMM tissues, the of Notch1 was positively correlated with that of Jagged1 （rs = 0.350, P = 0.027） and Dll4 （rs = 0.562, P < 0.001）, while the of Jagged1 was negatively correlated with that of Dll4 （rs = -0.734, P < 0.001）. Conclusion Abnormality of the Notch signaling pathway may be involved in the pathogenesis of melanoma, but further researches are still needed to elucidate the detailed mechanism.

刘白俞婉婷程伟邵雪宝姜祎群. Notch信号相关受体/配体在皮肤恶性黑素瘤中的表达[J]. 中华皮肤科杂志, 2017, 50(4): 252-256.doi:

参考文献 22

［1］	Gao J, Song Z, Chen Y, et al. Deregulated of Notch receptors in human hepatocellular carcinoma［J］. Dig Liver Dis, 2008, 40（2）: 114⁃121. DOI: 10.1016/j.dld.2007.08.001.
［2］	Gramantieri L, Giovannini C, Lanzi A, et al. Aberrant Notch3 and Notch4 in human hepatocellular carcinoma［J］. Liver Int, 2007, 27（7）: 997⁃1007. DOI: 10.1111/j.1478⁃3231.2007. 01544.x.
［3］	Konishi J, Kawaguchi KS, Vo H, et al. Gamma⁃secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers［J］. Cancer Res, 2007, 67（17）: 8051⁃8057. DOI: 10.1158/0008⁃5472.CAN⁃07⁃1022.
［4］	Donnem T, Andersen S, Al⁃Shibli K, et al. Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: co of Notch⁃1 and vascular endothelial growth factor⁃A predicts poor survival［J］. Cancer, 2010, 116（24）: 5676⁃5685. DOI: 10.1002/cncr.25551.
［5］	Chen J, Imanaka N, Chen J, et al. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E⁃cadherin and increased cell migration and invasion［J］. Br J Cancer, 2010, 102（2）: 351⁃360. DOI: 10.1038/sj.bjc.6605486.
［6］	Peng GL, Tian Y, Lu C, et al. Effects of Notch⁃1 down⁃regulation on malignant behaviors of breast cancer stem cells［J］. J Huazhong Univ Sci Technolog Med Sci, 2014, 34（2）: 195⁃200. DOI: 10.1007/s11596⁃014⁃1258⁃4.
［7］	Brzozowa M, Mielańczyk L, Michalski M, et al. Role of Notch signaling pathway in gastric cancer pathogenesis［J］. Contemp Oncol （Pozn）, 2013, 17（1）: 1⁃5. DOI: 10.5114/wo.2013.33765.
［8］	Nowell C, Radtke F. Cutaneous Notch signaling in health and disease［J］. Cold Spring Harb Perspect Med, 2013, 3（12）: a017772. DOI: 10.1101/cshperspect.a017772.
［9］	South AP, Purdie KJ, Watt SA, et al. NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis［J］. J Invest Dermatol, 2014, 134（10）: 2630⁃2638. DOI: 10.1038/jid.2014.154.
［10］	Massi D, Tarantini F, Franchi A, et al. Evidence for differential of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma［J］. Mod Pathol, 2006, 19（2）: 246⁃254. DOI: 10.1038/modpathol.3800526.
［11］	吴琼, 李阿梅, 邵雪宝, 等. 甲苯胺蓝染色在黑素瘤免疫组化复染中的应用［J］. 临床与实验病理学杂志, 2015, （8）: 941⁃942. DOI: 10.13315/j.cnki.cjcep.2015.08.029.
［12］	Murtas D, Piras F, Minerba L, et al. Activated Notch1 is associated with angiogenesis in cutaneous melanoma［J］. Clin Exp Med, 2015, 15（3）: 351⁃360. DOI: 10.1007/s10238⁃014⁃0300⁃y.
［13］	Qiu H, Tang X, Ma J, et al. Notch1 autoactivation via transcriptional regulation of furin, which sustains Notch1 signaling by processing Notch1⁃activating proteases ADAM10 and membrane type 1 matrix metalloproteinase［J］. Mol Cell Biol, 2015, 35（21）: 3622⁃3632. DOI: 10.1128/MCB.00116⁃15.
［14］	Basak A, Chen A, Scamuffa N, et al. Blockade of furin activity and furin⁃induced tumor cells malignant phenotypes by the chemi⁃cally synthesized human furin prodomain［J］. Curr Med Chem, 2010, 17（21）: 2214⁃2221. DOI: 10.2174/092986710791331040.
［15］	Hardy KM, Kirschmann DA, Seftor EA, et al. Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype［J］. Cancer Res, 2010, 70（24）: 10340⁃10350. DOI: 10.1158/0008⁃5472.CAN⁃10⁃0705.
［16］	Bedogni B. Notch signaling in melanoma: interacting pathways and stromal influences that enhance Notch targeting［J］. Pigment Cell Melanoma Res, 2014, 27（2）: 162⁃168. DOI: 10.1111/pcmr. 12194.
［17］	Kirschmann DA, Seftor EA, Hardy KM, et al. Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications［J］. Clin Cancer Res, 2012, 18（10）: 2726⁃2732. DOI: 10.1158/1078⁃0432.CCR⁃11⁃3237.
［18］	Qiu XX, Chen L, Wang CH, et al. The vascular notch ligands delta⁃like ligand 4 （DLL4） and Jagged1 （JAG1） have opposing correlations with microvascularization but a uniform prognostic effect in primary glioblastoma: a preliminary study［J］. World Neurosurg, 2016, 88: 447⁃458. DOI: 10.1016/j.wneu.2015.10. 058.
［19］	Pedrosa AR, Trindade A, Fernandes AC, et al. Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1［J］. Arterioscler Thromb Vasc Biol, 2015, 35（5）: 1134⁃1146. DOI: 10.1161/ATVBAHA.114.304741.
［20］	Benedito R, Rocha SF, Woeste M, et al. Notch⁃dependent VEGFR3 upregulation allows angiogenesis without VEGF⁃VEGFR2 signal⁃ling［J］. Nature, 2012, 484（7392）: 110⁃114. DOI: 10.1038/nature10908.
［21］	Siekmann AF, Affolter M, Belting HG. The tip cell concept 10 years after: new players tune in for a common theme［J］. Exp Cell Res, 2013, 319（9）: 1255⁃1263. DOI: 10.1016/j.yexcr.2013.01. 019.
［22］	Zhang J, Ye J, Ma D, et al. Cross⁃talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway［J］. Carcinogenesis, 2013, 34（3）: 667⁃677. DOI: 10.1093/carcin/bgs386.